Letters

Published: 04/03/2004, Volume II4, No. 5895 Page 25

The overlooked issue of costeffectiveness is rightly highlighted by Wanless as a key issue if public health is ever to get on the same footing as clinical interventions.

We need hard financial facts that clearly make the case for investment.Without it, we can't expect funders to put their money where our mouth is.

For years those of us who work in public health have complained about being bottom of everyone's 'to do' list. Let's not squander the opportunity now we are a bit further up.

Paul Streets Chief executive Health Development Agency